TOP STORIES

• REGULATORY Sumitomo to Urge Switch from Noritren over Carcinogen Risks, but Continues Shipments
  June 8, 2023

• REGULATORY Draft Honebuto Paper Unveiled, Cabinet OK Expected in Mid-June
  June 8, 2023

• REGULATORY Draft Honebuto Paper Calls for Further Drug Pricing Measures to Reward Innovation
  June 7, 2023

• ORGANIZATION Industry’s Concerns Beginning to Sink in among Policymakers: JPMA Committee Chair
  June 7, 2023

• BUSINESS Japan Firms Joining Fray in siRNA Drug Development; Takeda Could File as Early as FY2025
  June 6, 2023

• REGULATORY Expert Panel to Propose Setting Up Requirements for Generic Entry to Ensure Stable Supplies; Draft Report Due Out June 6
  June 5, 2023

• REGULATORY Expert Panel Pushes Fresh Evaluation Approach for New Drug Pricing, Rethink of Spillovers: Draft Report
  June 5, 2023

• BUSINESS Shionogi Shoots for Doubling Revenue to 800 Billion Yen by FY2030
  June 2, 2023

• BUSINESS Pharma Companies in Japan Raising Retirement Age, Extending Rehiring: Jiho Poll
  June 1, 2023

• BUSINESS AbbVie Aims to Double Japan Sales to 200 Billion Yen by 2030: Local Chief
  May 31, 2023

• REGULATORY Japan to Launch New Forum to Spur Secondary Use of Medical Data in Drug Discovery
  May 30, 2023

• REGULATORY MOF Panel Flags Japan’s High Drug Cost per Capita, Stays Pat on Cost-Effectiveness-Based Reimbursement, Copay Review
  May 30, 2023

• BUSINESS Jeremy Grossas to Head Up Merck Biopharma Japan
  May 30, 2023

• REGULATORY PM Advisors Make Irregular Call for Properly Rewarding Innovation to Boost Japan’s Drug Discovery Capabilities
  May 29, 2023

• REGULATORY Gene Therapy Luxturna Now in Line for Approval in June
  May 29, 2023

• BUSINESS Pfizer Japan Files RSV Vaccine for 60 Years of Age and Older
  May 29, 2023

• ORGANIZATION New JPMA Chief Renews Resolve for Drug Price Maintenance, Dynamic Policies
  May 26, 2023

• ORGANIZATION Mitsubishi Tanabe’s Ueno Elected as New JPMA President
  May 26, 2023

• REGULATORY Japan Approves Label Expansions for Ultomiris, Skyrizi, Vanflyta
  May 26, 2023

• BUSINESS Some 400 General Employees Likely Leaving Bayer under Redundancy Program
  May 25, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 53
• 54
• 55
• 56
• 57
• 58
• 59
• 60
• 61
• …
• Next ›
• 最終 »